We are live on ! Find out more
EC

EcoR1 Capital Portfolio holdings

AUM $2.34B
1-Year Est. Return 204.53%
This Fund
S&P 500
This Quarter Est. Return
+2.22%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$434M
AUM Growth
+$72.4M
Cap. Flow
+$84.9M
Cap. Flow %
19.57%
Top 10 Hldgs %
81.24%
Holding
46
New
12
Increased
6
Reduced
2
Closed
10

Top Buys

1
KYNB
Kyntra Bio
KYNB
+$43M
2
FBRX icon
Forte Biosciences
FBRX
+$22.5M
3
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$16.5M
4
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$14.7M
5
EDIT icon
Editas Medicine
EDIT
+$12.9M

Top Sells

1
ACRS icon
Aclaris Therapeutics
ACRS
+$13.3M
2
ATRA icon
Atara Biotherapeutics
ATRA
+$8.94M
3
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
+$5.68M
4
XNCR icon
Xencor
XNCR
+$5.62M
5
KURA icon
Kura Oncology
KURA
+$5.26M

Sector Composition

1 Healthcare 96.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGIO icon
26
Agios Pharmaceuticals
AGIO
$2.37B
$1.2M 0.28%
23,300
– –
CCXI
27
DELISTED
ChemoCentryx, Inc.
CCXI
$1.1M 0.25%
118,000
– –
BMY icon
28
Bristol-Myers Squibb
BMY
$120B
$951K 0.22%
17,060
– –
CLVS
29
DELISTED
Clovis Oncology, Inc.
CLVS
$936K 0.22%
+10,000
New +$612K
ALNY icon
30
Alnylam Pharmaceuticals
ALNY
$37.2B
$831K 0.19%
+10,425
New +$666K
SGEN
31
DELISTED
Seagen Inc. Common Stock
SGEN
$776K 0.18%
+15,000
New +$953K
PETX
32
DELISTED
Aratana Therapeutics, Inc.
PETX
$723K 0.17%
+100,000
New +$615K
ATRA icon
33
Atara Biotherapeutics
ATRA
$76.3M
– –
-17,392
Closed -$8.94M
GILD icon
34
Gilead Sciences
GILD
$164B
– –
0
– –
SNDX icon
35
Syndax Pharmaceuticals
SNDX
$2.08B
– –
-35,301
Closed -$484K
VRTX icon
36
Vertex Pharmaceuticals
VRTX
$121B
– –
0
– –
WVE icon
37
Wave Life Sciences
WVE
$1.14B
– –
-10,000
Closed -$275K
XNCR icon
38
Xencor
XNCR
$1.11B
– –
-234,813
Closed -$5.62M
SYRS
39
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
– –
-6,360
Closed -$1.01M
ARAV
40
DELISTED
Aravive, Inc. Common Stock
ARAV
– –
-16,667
Closed -$2.13M
JNCE
41
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-258,457
Closed -$5.68M
VIVE
42
DELISTED
VIVEVE MED INC
VIVE
– –
-250
Closed -$1.58M
ALXN
43
DELISTED
Alexion Pharmaceuticals
ALXN
– –
0
– –
FWP
44
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
– –
-718
Closed -$108K
OREX
45
DELISTED
Orexigen Therapeutics, Inc.
OREX
– –
-117,726
Closed -$405K
1
2

Similar funds

G
GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return
CC
Capital Counsel New York $2.35B AUM 21.34% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $2.33B AUM 92.42% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.33B AUM 20.04% 1-Year Est. Return
MFAM
Motley Fool Asset Management Alexandria, Virginia $2.33B AUM 21.93% 1-Year Est. Return